Search

Abstract: Aralia elata has long been used as a tonic, anticancer and antidiabetic agent in China and Japan, and is widely consumed as food. Phytochemical investigation of the leaves of A. elata has led to the isolation of four new compounds, 3-O-[β-d-glucopyranosyl(1→3)-β-d-glucopyranosyl] echinocystic acid 28-O-β-d-glucopyranosyl ester (congmuyenoside I, 1), 3-O-[β-d-glucopyranosyl(1→2)-β-d-glucopyranosyl] hederagenin 28-O-β-d-glucopyranosyl ester (congmuyenoside II, 2), 3-O-{[β-d-glucopyranosyl(1→2)]-[β-d-glucopyranosyl(1→3)-β-d-glucopyranosyl(1→3)]-β-d-glucopyranosyl} echinocystic acid 28-O-β-d-glucopyranosyl ester (congmuyenoside III, 3) and 3-O-β-d-glucopyranosyl caulophyllogenin 28-O-β-d-glucopyranosyl ester (congmuyenoside IV, 4), and eight known triterpene saponins (5–12). The structural determination was accomplished with spectroscopic analysis, in particularly 13C NMR, 2D NMR and HR-ESI-MS techniques. In addition, compounds 5–10 were found for the first time in the genus Aralia. Compounds 1–12 were tested for their inhibition of the growth of HL60, A549 and DU145 cancer cells. In addition, compound 8 showed significant cytotoxic activities against HL60, A549 and DU145 cancer cells with IC50 values of 15.62, 11.25 and 7.59μM, respectively. [Copyright &y& Elsevier]